Sangamo Therapeutics
SGMO
#9879
Rank
NZ$92.92 M
Marketcap
NZ$0.22
Share price
-5.46%
Change (1 day)
-70.06%
Change (1 year)

EPS for Sangamo Therapeutics (SGMO)

EPS in 2025 (TTM): NZ-$0.76

According to Sangamo Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$0.74. In 2024 the company made an earnings per share (EPS) of NZ-$0.86.

EPS history for Sangamo Therapeutics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.76-11.09%
2024NZ-$0.86
2022NZ-$2.100.81%
2021NZ-$2.0933.33%
2020NZ-$1.566.9%
2019NZ-$1.4622.54%
2018NZ-$1.191.43%
2017NZ-$1.18-31.37%
2016NZ-$1.7275.86%
2015NZ-$0.9848.72%
2014NZ-$0.66-17.02%
2013NZ-$0.799.3%
2012NZ-$0.72-39.44%
2011NZ-$1.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.70-2,085.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.37-3,390.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$15.73-2,225.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ-$6.71 806.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.53-1,656.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$5.99-908.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$6.38-961.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$2.36-418.18%๐Ÿ‡บ๐Ÿ‡ธ USA